Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 148, Issue 3, 2010, Pages 484-486

  Anoop, Parameswaran ^a   Wotherspoon, Andy ^a   Matutes, Estella ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Hepatitis; Infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALEMTUZUMAB; ALPHA2A INTERFERON; CYCLOPHOSPHAMIDE; FLUDARABINE; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; PREDNISONE; PROTEIN P53; RIBAVIRIN; RITUXIMAB; VIRUS RNA;

ADULT; AUTOIMMUNE DISEASE; CASE REPORT; CHROMATIN; CHROMOSOME 11Q; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; CYTOMEGALOVIRUS; DRUG TOLERANCE; HEMOLYSIS; HEMOLYTIC ANEMIA; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; MULTIPLE CYCLE TREATMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS; SPLENOMEGALY; TREATMENT RESPONSE; TRISOMY 12; VIRUS LOAD; VIRUS REACTIVATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; VIRUS ACTIVATION;

EID: 74049158284     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07972.x     Document Type: Letter

References (9)

1. Besson, C., Canioni, D., Lepage, E., Pol, S., Morel, P., Lederlin, P., Van Hoof, A., Tilly, H., Gaulard, P., Coiffier, B., Gisselbrecht, C., Brousse, N., Reyes, F. Hermine, O. Groupe d'Etude des Lymphomes de l'Adulte Programs (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98. Journal of Clinical Oncology, 24, 953 960.
2. Ennishi, D., Yokoyama, M., Terui, Y., Takeuchi, K., Ikeda, K., Tanimoto, M. Hatake, K. (2008a) Does rituximab really induce hepatitis C virus reactivation? Journal of Clinical Oncology, 26, 4695 4696.
3. Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Okamoto, H., Tanimoto, M. Hatake, K. (2008b) Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy. American Journal of Hematology, 83, 59 62.
4. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood, 111, 5446 5456.
5. Hsieh, C.Y., Huang, H.H., Lin, C.Y., Chung, L.W., Liao, Y.M., Bai, L.Y. Chiu, C.F. (2008) Rituximab induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. Journal of Clinical Oncology, 26, 2584 2586.
6. Melisko, M.E., Fox, R. Venook, A. (2004) Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)), 16, 204 205.
7. Milligan, D.W., Fernandes, S., Dasgupta, R., Davies, F.E., Matutes, E., Fegan, C.D., McConkey, C., Child, J.A., Cunningham, D., Morgan, G.J. Catovsky, D. (2005) Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. Blood, 105, 397 404.
8. Rommel, F., Toepfer, M., Eberle, J., Schiffl, H., Spannagl, M. Schramm, W. (2000) Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia. Thrombosis and Haemostasis, 84, 733 734.
9. Zuckerman, E., Zuckerman, T., Douer, D., Qian, D. Levine, A.M. (1998) Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer, 83, 1224 1230.